MEDIWELCOME HEALTHCARE MANAGEMENT & TECHNOLOGY INC. Financials Mediwelcome Healthcare Management & Technology Inc.
Equities
2159
KYG5960A1076
Business Support Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.385 HKD | 0.00% |
|
-3.75% | -24.51% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 216.7 | 243.8 | 92.71 |
| Enterprise Value (EV) 1 | 67.09 | 116.2 | 43.49 |
| P/E ratio | 42.5 x | -2.54 x | -0.94 x |
| Yield | - | - | - |
| Capitalization / Revenue | 0.31 x | 0.75 x | 0.28 x |
| EV / Revenue | 0.09 x | 0.36 x | 0.13 x |
| EV / EBITDA | 5.93 x | -1.24 x | -0.55 x |
| EV / FCF | -2.58 x | 15.7 x | -0.68 x |
| FCF Yield | -38.8% | 6.36% | -148% |
| Price to Book | 0.77 x | 1.25 x | 0.8 x |
| Nbr of stocks (in thousands) | 200,000 | 200,000 | 200,000 |
| Reference price 2 | 1.084 | 1.219 | 0.4635 |
| Announcement Date | 22-04-28 | 23-04-27 | 24-04-25 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 299 | 427.2 | 432.3 | 708.4 | 323.4 | 331.3 |
| EBITDA 1 | 49.89 | 40.7 | 34.9 | 11.32 | -93.79 | -79.32 |
| EBIT 1 | 47.24 | 36.64 | 28.94 | 6.672 | -97.04 | -81.92 |
| Operating Margin | 15.8% | 8.58% | 6.69% | 0.94% | -30.01% | -24.72% |
| Earnings before Tax (EBT) 1 | 49.15 | 25.97 | 22.28 | 5.588 | -91.04 | -96.38 |
| Net income 1 | 38.04 | 20.85 | 21.04 | 4.645 | -89.2 | -94.1 |
| Net margin | 12.72% | 4.88% | 4.87% | 0.66% | -27.58% | -28.4% |
| EPS | - | 0.1390 | 0.1403 | 0.0255 | -0.4801 | -0.4915 |
| Free Cash Flow 1 | 54.77 | -14.94 | 15.71 | -26.03 | 7.394 | -64.16 |
| FCF margin | 18.32% | -3.5% | 3.63% | -3.67% | 2.29% | -19.36% |
| FCF Conversion (EBITDA) | 109.77% | - | 45.03% | - | - | - |
| FCF Conversion (Net income) | 143.97% | - | 74.68% | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 20-12-24 | 20-12-24 | 21-04-27 | 22-04-28 | 23-04-27 | 24-04-25 |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 92.4 | 87.4 | 79.5 | 150 | 128 | 49.2 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 54.8 | -14.9 | 15.7 | -26 | 7.39 | -64.2 |
| ROE (net income / shareholders' equity) | 35.2% | 16.3% | 13.9% | 2.24% | -37.9% | -59.9% |
| ROA (Net income/ Total Assets) | 17.2% | 10.6% | 7.1% | 1.29% | -17.7% | -19.2% |
| Assets 1 | 221.3 | 197 | 296.4 | 360.2 | 503.4 | 489 |
| Book Value Per Share | - | 0.9100 | 1.070 | 1.420 | 0.9800 | 0.5800 |
| Cash Flow per Share | - | 0.4900 | 0.5900 | 0.8300 | 0.6900 | 0.4000 |
| Capex 1 | 3.13 | 2.14 | 5.03 | 2.32 | 1.41 | 1.4 |
| Capex / Sales | 1.05% | 0.5% | 1.16% | 0.33% | 0.44% | 0.42% |
| Announcement Date | 20-12-24 | 20-12-24 | 21-04-27 | 22-04-28 | 23-04-27 | 24-04-25 |
1CNY in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -24.51% | 9.86M | |
| +8.76% | 14.39B | |
| -1.00% | 1.21B | |
| -10.74% | 696M | |
| -0.11% | 635M | |
| +1.94% | 630M | |
| +47.56% | 293M | |
| +12.34% | 273M | |
| 0.00% | 263M | |
| +53.25% | 156M |
- Stock Market
- Equities
- 2159 Stock
- Financials Mediwelcome Healthcare Management & Technology Inc.